Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 363.15
+3.50 (0.97%)
May 4, 2026, 2:10 PM IST
Biocon Employees
Biocon had 16,420 employees as of September 30, 2025. The number of employees increased by 105 or 0.64% compared to the previous year.
Employees
16,420
Change
105
Growth
0.64%
Revenue / Employee
10.25M INR
Profits / Employee
367.97K INR
Market Cap
582.05B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 16,420 | 105 | 0.64% |
| Mar 31, 2024 | 16,315 | -230 | -1.39% |
| Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
| Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
| Mar 31, 2021 | 13,500 | 891 | 7.07% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Panacea Biotec | 2,149 |
| Concord Biotech | 1,571 |
| OneSource Specialty Pharma | 1,412 |
| Dishman Carbogen Amcis | 1,106 |
| Haleos Labs | 592 |
| Zota Health Care | 519 |
| Supriya Lifescience | 515 |
| Lyka Labs | 499 |
Biocon News
- 4 days ago - Pharma sector stocks today, April 30: Biocon falls 1.01%, Torrent Pharma down 0.95%, Zydus Lifesciences drops 0.85% - Business Upturn
- 4 days ago - Biocon receives five observations from U.S. FDA after pre-license inspection - Business Upturn
- 4 days ago - Biocon reports Rs 200 crore commercial paper issuance for March quarter - Business Upturn
- 10 days ago - Gadkari promised to repair Hosur Rd by April-end: Shaw - The Times of India
- 13 days ago - Biocon secures Health Canada approval for Bosaya and Vevzuo biosimilars - Business Upturn
- 13 days ago - Biocon issues reminder for KYC updates to shareholders with physical holdings - Business Upturn
- 21 days ago - Pharma sector stocks fall today, April 13: Biocon falls 2.35%, Cipla down 1.66%, Ajanta Pharma gains 0.77% - Business Upturn
- 26 days ago - Biocon shares jump over 3% after US FDA nod for diabetes drug Dapagliflozin tablets - Business Upturn